Xiao‐Dong Mo
Peking University(CN)Peking University People's Hospital(CN)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Cytomegalovirus and herpesvirus research, Polyomavirus and related diseases
Most-Cited Works
- → Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets(2015)199 cited
- → Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis(2017)177 cited
- → Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation(2016)111 cited
- → Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation(2021)91 cited
- → Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study(2020)84 cited
- → Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia(2016)84 cited
- → Laparoscopic Exploration of Common Bile Duct with Primary Closure Versus T-Tube Drainage: A Randomized Clinical Trial(2009)83 cited
- → Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial(2021)81 cited
- → Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation(2018)67 cited
- → Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts(2019)66 cited